[go: up one dir, main page]

AU6069300A - Novel human genes and gene expression products - Google Patents

Novel human genes and gene expression products

Info

Publication number
AU6069300A
AU6069300A AU60693/00A AU6069300A AU6069300A AU 6069300 A AU6069300 A AU 6069300A AU 60693/00 A AU60693/00 A AU 60693/00A AU 6069300 A AU6069300 A AU 6069300A AU 6069300 A AU6069300 A AU 6069300A
Authority
AU
Australia
Prior art keywords
gene expression
expression products
human genes
novel human
genes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU60693/00A
Inventor
Radomir Crkenjakov
Mark Dickson
Radoje Drmanac
Snezana Drmanac
Jaime Escobedo
Pablo Dominguez Garcia
Veronica Garcia
Michael A. Innis
Lee William Jones
Altaf Kassam
Guilia C. Kennedy
David Kita
Julie Klinger
Ivan Labat
George Lamson
Dena Leshkowitiz
David Pot
Filippo Randazzo
Christoph Reinhard
Birgit Strache-Crain
Lewis T. Williams
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis Vaccines and Diagnostics Inc
Hyseq Inc
Original Assignee
Hyseq Inc
Chiron Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hyseq Inc, Chiron Corp filed Critical Hyseq Inc
Publication of AU6069300A publication Critical patent/AU6069300A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/90—Isomerases (5.)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
AU60693/00A 1999-07-02 2000-06-30 Novel human genes and gene expression products Abandoned AU6069300A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US14231199P 1999-07-02 1999-07-02
US14231099P 1999-07-02 1999-07-02
US60/142310 1999-07-02
US60/142311 1999-07-02
PCT/US2000/018374 WO2001002568A2 (en) 1999-07-02 2000-06-30 Human genes and gene expression products

Publications (1)

Publication Number Publication Date
AU6069300A true AU6069300A (en) 2001-01-22

Family

ID=26839967

Family Applications (1)

Application Number Title Priority Date Filing Date
AU60693/00A Abandoned AU6069300A (en) 1999-07-02 2000-06-30 Novel human genes and gene expression products

Country Status (4)

Country Link
EP (1) EP1194549A2 (en)
JP (1) JP2003518920A (en)
AU (1) AU6069300A (en)
WO (1) WO2001002568A2 (en)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030170864A1 (en) 2000-05-30 2003-09-11 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US8101349B2 (en) 1997-12-23 2012-01-24 Novartis Vaccines And Diagnostics, Inc. Gene products differentially expressed in cancerous cells and their methods of use II
US6462187B1 (en) 2000-06-15 2002-10-08 Millennium Pharmaceuticals, Inc. 22109, a novel human thioredoxin family member and uses thereof
CA2503475A1 (en) * 1998-12-01 2000-06-08 Genentech, Inc. Promotion or inhibition of angiogenesis and cardiovascularization
EP1277833B1 (en) * 1999-02-12 2006-02-22 Genentech, Inc. Gene that is amplified in tumours, and related materials and methods
US6759508B2 (en) 2000-09-01 2004-07-06 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US6951738B2 (en) 1999-07-16 2005-10-04 Human Genome Sciences, Inc. Human tumor necrosis factor receptors TR13 and TR14
KR100543857B1 (en) * 1999-09-01 2006-01-23 제넨테크, 인크. Promote or inhibit angiogenesis and cardiovascularization
AU4018201A (en) * 1999-09-23 2001-04-24 Incyte Genomics, Inc. Molecules for diagnostics and therapeutics
US7029895B2 (en) 1999-09-27 2006-04-18 Millennium Pharmaceuticals, Inc. 27411, a novel human PGP synthase
FR2800388A1 (en) * 1999-10-29 2001-05-04 Pf Medicament CLONING, EXPRESSION AND CHARACTERIZATION OF A GENE EXPRESSED IN TUMOR CELLS AND INVOLVED IN REGULATION OF THE IMMUNE RESPONSE
EP1690872A3 (en) * 1999-12-01 2006-08-23 Genentech, Inc. Composition and methods for the diagnosis of tumours
US20020156238A1 (en) * 1999-12-09 2002-10-24 Peyman John A. Novel polypeptides and polynucleotides encoding same
WO2001044472A1 (en) * 1999-12-16 2001-06-21 Amgen, Inc. Tnfr/opg-like molecules and uses thereof
US20020038012A1 (en) * 2000-02-22 2002-03-28 Gregory Donoho Novel human regulatory protein and polynucleotides encoding the same
AU2001243293A1 (en) * 2000-02-25 2001-09-03 Biogen, Inc. Sodium/solute symporter-like protein and nucleic acids encoding same
EP1261719B1 (en) 2000-02-28 2006-12-20 Bayer HealthCare AG 27411, a human phosphatidyl-glycerolphosphate (pgp) synthase
US6413757B1 (en) 2000-02-28 2002-07-02 Millennium Pharmaceuticals, Inc. 25312, a novel human agmatinase-like homolog
WO2001066764A2 (en) 2000-03-07 2001-09-13 Millennium Pharmaceuticals, Inc. 16835, a human phospholipase c and uses thereof
WO2001066753A2 (en) * 2000-03-09 2001-09-13 Chiron Corporation Human genes and gene expression products
US6627423B2 (en) 2000-03-24 2003-09-30 Millennium Pharmaceuticals, Inc. 21481, a novel dehydrogenase molecule and uses therefor
US6511834B1 (en) 2000-03-24 2003-01-28 Millennium Pharmaceuticals, Inc. 32142,21481,25964,21686, novel human dehydrogenase molecules and uses therefor
US6500657B1 (en) * 2000-03-31 2002-12-31 Millennium Pharmaceuticals, Inc. 33167, a novel human hydrolase and uses therefor
CA2405730A1 (en) * 2000-04-10 2001-10-18 Merck Patent Gesellschaft Mit Beschraenkter Haftung Serine-threonine kinase
AU6531101A (en) * 2000-06-02 2001-12-17 Genentech Inc Secreted and transmembrane polypeptides and nucleic acids encoding the same
US7358353B2 (en) 2000-08-22 2008-04-15 Agensys, Inc. Nucleic acid and corresponding protein named 158P1D7 useful in the treatment and detection of bladder and other cancers
PT1854809E (en) 2000-08-22 2012-12-26 Agensys Inc Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers
EP1317527A2 (en) * 2000-09-15 2003-06-11 Institut National De La Sante Et De La Recherche Medicale (Inserm) Cellular genes involved in oncogenesis, products of said genes and their diagnostic and therapeutic uses
FR2814176A1 (en) * 2000-09-15 2002-03-22 Inst Nat Sante Rech Med New nucleic acid implicated in oncogenesis, useful for diagnosis and treatment of cancer, also related polypeptides and antibodies
ES2335478T3 (en) * 2000-10-05 2010-03-29 Millennium Pharmaceuticals, Inc. 32144, A HUMAN HYDROLASE OF AMIDAS OF FATTY ACIDS AND ITS USES.
US7208267B2 (en) 2000-11-22 2007-04-24 Diadexus, Inc. Compositions and methods relating to breast specific genes and proteins
EP1356046B1 (en) 2000-11-28 2009-10-14 ZymoGenetics, L.L.C. Cytokine receptor zcytor19
JPWO2002050269A1 (en) * 2000-12-21 2004-04-22 株式会社ジェノックス創薬研究所 Testing methods for allergic diseases
US20060063230A1 (en) 2000-12-27 2006-03-23 Roman Naworth Sulfatases and methods of use thereof
US7601825B2 (en) 2001-03-05 2009-10-13 Agensys, Inc. Nucleic acid and corresponding protein entitled 121P1F1 useful in treatment and detection of cancer
US6924358B2 (en) 2001-03-05 2005-08-02 Agensys, Inc. 121P1F1: a tissue specific protein highly expressed in various cancers
US7271240B2 (en) 2001-03-14 2007-09-18 Agensys, Inc. 125P5C8: a tissue specific protein highly expressed in various cancers
WO2002083921A2 (en) 2001-04-10 2002-10-24 Agensys, Inc. Nuleic acids and corresponding proteins useful in the detection and treatment of various cancers
US7157558B2 (en) 2001-06-01 2007-01-02 Genentech, Inc. Polypeptide encoded by a polynucleotide overexpresses in tumors
EP2339029B1 (en) 2001-09-14 2016-03-09 Clinical Genomics Pty. Ltd Nucleic acid markers for use in determining predisposition to neoplasm and/or adenoma
AU2002359252A1 (en) 2001-10-05 2003-04-22 Keck Graduate Institute Of Applied Life Sciences Human tyrosine-dna phosphodiesterase variant polypeptides and methods of use therefor
US7033787B2 (en) * 2001-12-21 2006-04-25 Ludwig Institute For Cancer Research Isolated cytokine receptor LICR-2
JP4409962B2 (en) 2002-04-19 2010-02-03 ザイモジェネティクス，インコーポレイティド Cytokine receptor
EP1573038A2 (en) 2002-07-19 2005-09-14 Arizona Board Of Regents A high resolution typing system for pathogenic mycobacterium tuberculosum
US7723477B2 (en) 2005-10-31 2010-05-25 Oncomed Pharmaceuticals, Inc. Compositions and methods for inhibiting Wnt-dependent solid tumor cell growth
BRPI0919473A2 (en) 2008-09-26 2017-08-29 Oncomed Pharm Inc FRIZZLED BINDING AGENTS AND THEIR USES
TWI535445B (en) 2010-01-12 2016-06-01 安可美德藥物股份有限公司 Wnt antagonists and methods of treatment and screening
NZ602700A (en) 2010-04-01 2014-10-31 Oncomed Pharm Inc Frizzled-binding agents and uses thereof
EP3903812A1 (en) 2010-09-29 2021-11-03 Agensys, Inc. Antibody drug conjugates (adc) that bind to 191p4d12 proteins
DK2887959T3 (en) 2012-08-23 2019-02-18 Agensys Inc ANTIBODY-PHARMACEUTICAL CONJUGATES (ADC) BINDING TO 158P1D7 PROTEINS
AU2014212081A1 (en) 2013-02-04 2015-08-13 Oncomed Pharmaceuticals, Inc. Methods and monitoring of treatment with a Wnt pathway inhibitor
US9168300B2 (en) 2013-03-14 2015-10-27 Oncomed Pharmaceuticals, Inc. MET-binding agents and uses thereof
WO2015084808A1 (en) * 2013-12-02 2015-06-11 Oncomed Pharmaceuticals, Inc. Identification of predictive biomarkers associated with wnt pathway inhibitors
JP7514834B2 (en) 2018-12-03 2024-07-11 アジェンシス，インコーポレイテッド Pharmaceutical compositions comprising anti-191P4D12 antibody drug conjugates and methods of use thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2728697A (en) * 1996-04-19 1997-11-12 Genetics Institute Inc. Secreted proteins and polynucleotides encoding them

Also Published As

Publication number Publication date
WO2001002568A3 (en) 2001-08-30
JP2003518920A (en) 2003-06-17
WO2001002568A2 (en) 2001-01-11
EP1194549A2 (en) 2002-04-10

Similar Documents

Publication Publication Date Title
AU6069300A (en) Novel human genes and gene expression products
AU4053699A (en) Novel human genes and gene expression products
AU4187499A (en) Human genes and gene expression products v
AU2095599A (en) Human genes and gene expression products i
AU2001245619A1 (en) Human genes and gene expression products
AU2001285047A1 (en) Human genes and gene expression products
AU2001249125A1 (en) Human fgf-23 gene and gene expression products
AU2001245535A1 (en) Human fgf-23 gene and gene expression products
AU6418498A (en) Human genes
AU2839401A (en) Enzymes and genes used for producing vanillin
AU2002327607A1 (en) Human genes and gene expression products isolated from human prostate
AU4329300A (en) Human mesenchymal dnas and expression products
AU3072500A (en) Rhamnosyl-transferase gene and uses thereof
AU1101901A (en) Human fgf-20 gene and gene expression products
AUPQ262599A0 (en) Gene expression
AU6263999A (en) Human genes and gene expression products
AU2001226922A1 (en) Cancer associated genes and their products
AU3133799A (en) Seed-coat promoters, genes and gene products
AU2001287269A1 (en) Human genes and expression products
AU2002243300A1 (en) Human genes and gene expression products isolated from human prostate
AU6773200A (en) Egfh2 genes and gene products
AU2400401A (en) Novel phosphodiesterases and genes thereof
AU2153401A (en) Gene expression in biological conditions
AU3457899A (en) Blk genes, gene products and uses thereof in apoptosis
AU1894601A (en) Novel gene and use thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase